Oakland, CA 的 伯基特淋巴瘤 臨床試驗
6 項針對 伯基特淋巴瘤 的研究正在 Oakland（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
招募中2 期
- UCSF Benioff Children's Hospital Oakland, Oakland
- Kaiser Permanente-Oakland, Oakland
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
招募中3 期
- Kaiser Permanente-Oakland, Oakland
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
招募中2 期
- UCSF Benioff Children's Hospital Oakland, Oakland
- Kaiser Permanente-Oakland, Oakland
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
招募中2 期
- Kaiser Permanente-Oakland, Oakland
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
招募中3 期
- UCSF Benioff Children's Hospital Oakland, Oakland
- Kaiser Permanente-Oakland, Oakland
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
招募中2 期
- UCSF Benioff Children's Hospital Oakland, Oakland
其他城市的 伯基特淋巴瘤 試驗
- Houston, TX21 項研究
- Philadelphia, PA16 項研究
- Milwaukee, WI16 項研究
- Chicago, IL15 項研究
- Cincinnati, OH13 項研究
- New York City, NY13 項研究
- Atlanta, GA12 項研究
- Aurora, CO11 項研究
- Seattle, WA11 項研究
- Durham, NC10 項研究
- Boston, MA10 項研究
- Kansas City, MO10 項研究
Oakland 的其他研究
- 乳癌7 項研究
- 急性髓系白血病7 項研究
- 鐮狀細胞病7 項研究
- 非小細胞肺癌6 項研究
- 肺癌6 項研究
- 前列腺癌6 項研究
- 神經母細胞瘤5 項研究
- 癌症（所有類型）5 項研究
- 骨肉瘤4 項研究
- 阿茲海默症4 項研究
- 食道腺癌4 項研究
- 黑色素瘤4 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。